JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M403674200 on November 1, 2004

J. Biol. Chem., Vol. 280, Issue 2, 1016-1023, January 14, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/2/1016    most recent
M403674200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hupfeld, C. J.
Right arrow Articles by Olefsky, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hupfeld, C. J.
Right arrow Articles by Olefsky, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Insulin-induced {beta}-Arrestin1 Ser-412 Phosphorylation Is a Mechanism for Desensitization of ERK Activation by G{alpha}i-coupled Receptors*

Christopher J. Hupfeld{ddagger}, Jamie L. Resnik§, Satoshi Ugi{ddagger}, and Jerrold M. Olefsky{ddagger}¶||**

From the {ddagger}Department of Medicine, Division of Endocrinology and Metabolism and the §Department of Reproductive Medicine, University of California, San Diego, La Jolla, California 92093, the Veterans Affairs Hospital, Research Service, San Diego, California 92161, and ||The Whittier Diabetes Institute, La Jolla, California 92037

{beta}-Arrestin1 is an adapter/scaffold for many G protein-coupled receptors during mitogen-activated protein kinase signaling. Phosphorylation of {beta}-arrestin1 at position Ser-412 is a regulator of {beta}-arrestin1 function, and in the present study, we showed that insulin led to a time- and dose-dependent increase in {beta}-arrestin1 Ser-412 phosphorylation, which blocked isoproterenol- and lysophosphatidic acid-induced Ser-412 dephosphorylation and impaired ERK signaling by these G protein-coupled receptor ligands. Insulin treatment also led to accumulation of Ser-412-phosphorylated {beta}-arrestin1 at the insulin-like growth factor 1 receptor and prevented insulin-like growth factor 1/Src association. Insulin-induced Ser-412 phosphorylation was partially dependent on ERK as treatment with the MEK inhibitor PD98059 inhibited the insulin effect (62% reduction, p = 0.03). Inhibition of phosphatidylinositol 3-kinase by wortmannin did not have a significant effect (9% reduction, p = 0.41). We also found that the protein phosphatase 2A (PP2A) was in a molecular complex with {beta}-arrestin1 and that the PP2A inhibitor okadaic acid increased Ser-412 phosphorylation. Concomitant addition of insulin and okadaic acid did not produce an additive effect on Ser-412 phosphorylation, suggesting a common mechanism. Small t antigen specifically inhibited PP2A, and in HIRcB cells expressing small t antigen, {beta}-arrestin1 Ser-412 phosphorylation was increased, and insulin had no further effect. Insulin treatment caused increased {beta}-arrestin1 Ser-412 phosphorylation, which blocked mitogen-activated protein kinase signaling and internalization by {beta}-arrestin1-dependent receptors with no effect on {beta}-adrenergic receptor Gs-mediated cAMP production. These findings provide a new mechanism for insulin-induced desensitization of ERK activation by G{alpha}i-coupled receptors.


Received for publication, April 2, 2004 , and in revised form, October 12, 2004.

* This work was supported by National Institutes of Health Grant K08 DK65127-01 (to C. J. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: Dept. of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-6073. Tel.: 858-534-6651; Fax: 858-534-6653; E-mail: jolefsky{at}ucsd.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Lee, S. Bhatt, A. Shukla, R. W. Desnoyer, S. P. Yadav, M. Kim, S.-H. Jang, and S. S. Karnik
Site-specific Cleavage of G Protein-coupled Receptor-engaged {beta}-Arrestin: INFLUENCE OF THE AT1 RECEPTOR CONFORMATION ON SCISSILE SITE SELECTION
J. Biol. Chem., August 1, 2008; 283(31): 21612 - 21620.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Sonoda, T. Imamura, T. Yoshizaki, J. L. Babendure, J.-C. Lu, and J. M. Olefsky
{beta}-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic {beta} cells
PNAS, May 6, 2008; 105(18): 6614 - 6619.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. C. Galownia, K. Kushiro, Y. Gong, and A. R. Asthagiri
Selective Desensitization of Growth Factor Signaling by Cell Adhesion to Fibronectin
J. Biol. Chem., July 27, 2007; 282(30): 21758 - 21766.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. M. Swift, M. R. Schwarb, K. A. Mihlbachler, and S. B. Liggett
Pleiotropic beta-Agonist-Promoted Receptor Conformations and Signals Independent of Intrinsic Activity
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 236 - 243.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. G. Buchanan, D. L. Gorden, P. Matta, Q. Shi, L. M. Matrisian, and R. N. DuBois
Role of beta-arrestin 1 in the metastatic progression of colorectal cancer
PNAS, January 31, 2006; 103(5): 1492 - 1497.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Van Kanegan, D. G. Adams, B. E. Wadzinski, and S. Strack
Distinct Protein Phosphatase 2A Heterotrimers Modulate Growth Factor Signaling to Extracellular Signal-regulated Kinases and Akt
J. Biol. Chem., October 28, 2005; 280(43): 36029 - 36036.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. J. Lefkowitz and S. K. Shenoy
Transduction of Receptor Signals by {beta}-Arrestins
Science, April 22, 2005; 308(5721): 512 - 517.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.